Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Jérémie Roux

5PUBLICATIONS

19CO-AUTHORS

Molecular targets

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (5)

Sort by Publication Date:

|Oct 01, 2025

Transition between cell states of sensitivity reveals molecular vulnerability of drug-tolerant cells.

Ludovic Peyre, Marielle Péré, Mickael Meyer

|Jun 28, 2023

KRAS and NRAS Translation Is Increased upon MEK Inhibitors-Induced Processing Bodies Dissolution.

Olivia Vidal-Cruchez, Victoria J Nicolini, Tifenn Rete

|Nov 07, 2022

Gene prioritization based on random walks with restarts and absorbing states, to define gene sets regulating drug pharmacodynamics from single-cell analyses.

Augusto Sales de Queiroz, Guilherme Sales Santa Cruz, Alain Jean-Marie

|Dec 01, 2020

TRAIL receptor-induced features of epithelial-to-mesenchymal transition increase tumour phenotypic heterogeneity: potential cell survival mechanisms.

Ludovic Peyre, Mickael Meyer, Paul Hofman

|Jun 03, 2017

Bi-specific molecule against EGFR and death receptors simultaneously targets proliferation and death pathways in tumors.

Yanni Zhu, Nicole Bassoff, Clemens Reinshagen

Pageof 1

Frequent Collaborators

2 joint publications

Bernard Mari

1 joint publications

Clemens Reinshagen

1 joint publications

Alain Jean-Marie

1 joint publications

Dorian Mazauric

1 joint publications

Frédéric Cazals

1 joint publications

Olivia Vidal-Cruchez

1 joint publications

Victoria J Nicolini

1 joint publications

Tifenn Rete

1 joint publications

Karine Jacquet

1 joint publications

Roger Rezzonico

Frequent Collaborators

2 joint publications

Bernard Mari

1 joint publications

Clemens Reinshagen

1 joint publications

Alain Jean-Marie

1 joint publications

Dorian Mazauric

Top Related Videos

Implementation of <em>In Vitro</em> Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

Implementation of <em>In Vitro</em> Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

Published on : Dec 09, 2015

Fully Processed Recombinant KRAS4b: Isolating and Characterizing the Farnesylated and Methylated Protein

Fully Processed Recombinant KRAS4b: Isolating and Characterizing the Farnesylated and Methylated Protein

Published on : Jan 16, 2020

Genetic Profiling and Genome-Scale Dropout Screening to Identify Therapeutic Targets in Mouse Models of Malignant Peripheral Nerve Sheath Tumor

Genetic Profiling and Genome-Scale Dropout Screening to Identify Therapeutic Targets in Mouse Models of Malignant Peripheral Nerve Sheath Tumor

Published on : Aug 25, 2023

See more related videos

Top Related Videos

Implementation of <em>In Vitro</em> Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

Implementation of <em>In Vitro</em> Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

Published on : Dec 09, 2015

Fully Processed Recombinant KRAS4b: Isolating and Characterizing the Farnesylated and Methylated Protein

Fully Processed Recombinant KRAS4b: Isolating and Characterizing the Farnesylated and Methylated Protein

Published on : Jan 16, 2020

Genetic Profiling and Genome-Scale Dropout Screening to Identify Therapeutic Targets in Mouse Models of Malignant Peripheral Nerve Sheath Tumor

Genetic Profiling and Genome-Scale Dropout Screening to Identify Therapeutic Targets in Mouse Models of Malignant Peripheral Nerve Sheath Tumor

Published on : Aug 25, 2023

See more related videos